Cytokine use in the management of HIV disease

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue SUPPL. 1, 1997, Pages

  Scadden, David T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anemia; Cytokines; Erythropoietin; G CSF; GM CSF; Growth factors; HIV; Neutropenia

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANEMIA; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CONFERENCE PAPER; HEMATOCRIT; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUTROPENIA; PRIORITY JOURNAL; PROPHYLAXIS;

CYTOKINES; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOLOGIC DISEASES; HIV; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-3; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030864296     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199701001-00004     Document Type: Article

References (42)

1. Groopman JE, Molina J-M, Scadden DT. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med 1989;321: 1449-59.
2. Bondurant MC, Koury MJ. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol Cell Biol 1986;6: 2731-3.
3. Hill ADK, Naama HA, Calvano SE, Daly JM. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J Leukocyte Biol 1995;58:634-42.
4. Groopman JE, Mitsuyasu RT, DeLeo MJ, Oette DH, Golde DW. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 1987;317:593-8.
5. Nathan CF. Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 1989;73:301-6.
6. Wang JM, Colella S, Allavena P, Mantovani A. Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. Immunology 1987;60:439-44.
7. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78:2791-808.
8. Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986;232:61-5.
9. Zon LI, Groopman JE. Hematologic manifestations of human immune deficiency virus (HIV). Semin Hematol 1988;25:208-18.
10. Scadden DT, Zon LI, Groopman JE. Pathophysiology and management of HIV-associated hematologic disorders. Blood 1989;74: 1455-63.
11. Scadden DT. The use of GM-CSF in AIDS. Infection 1992;20 (suppl 2):S103-6.
12. Pluda JM, Mitsuya H, Yarchoan R. Hematologic effects of AIDS therapies. Hematol Oncol Clin North Am 1991;5:229-48.
13. Groopman JE. Zidovudine intolerance. Rev Infect Dis 1990;12 (suppl 1):S500-6.
14. Hambleton J. Hematologic complications of HIV infection. Oncology 1996;10:671-80.
15. Creagh-Kirk T, Doi P, Andrews E, et al. Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program. JAMA 1988;260:3009-15.
16. Wenger JD, Whalen CC, Lederman MM, et al. Prognostic factors in acquired immunodeficiency syndrome. J Gen Intern Med 1988; 3:464-70.
17. Phair JP, Abels RI, McNeill MV, Sullivan DJ. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Arch Intern Med 1993;153:2669-75.
18. Fischl MA, Richman DD, Grieco MH, et al., and the AZT Collaborative Working Group. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317: 185-91.
19. Hengge UR, Brockmeyer NH, Goos M. Granulocyte colony-stimulating factor treatment in AIDS patients. Clin Invest 1992; 70:922-6.
20. Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infections in AIDS [Abstract]. Proc Thirty-fifth ICAAC, 1995;I249.
21. Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488-93.
22. Henry DH, Beall GN, Benson CA, et al. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med 1992;117:739-48.
23. Vamvakas E, Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 1993;33:111-8.
24. Mudido PM, Georges D, Dorazio D, et al. Human immunodeficiency virus type 1 activation after blood transfusion. Transfusion 1996;36:860-5.
25. Lancaster DJ, Palte S, Ray D. Recombinant human erythropoietin in the treatment of anemia in AIDS patients receiving concomitant amphotericin B and zidovudine. J Acquir Immune Defic Syndr 1993;6:533-4.
26. Levine JD, Allan JD, Tessitore JH, et al. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Blood 1991;78:3148-54.
27. Pluda JM, Yarchoan R, Smith PD, et al. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood 1990;76:463-72.
28. Hardy WD. Combined ganciclovir and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. J Acquir Immune Defic Syndr 1991;4(suppl 1):S22-8.
29. Kaplan LD, Kahn JO, Crowe S, et al. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol 1991;9:929-40.
30. Garavelli PL, Berti P. Efficacy of recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenia. AIDS 1993;7:589-90.
31. Kimura S, Matsuda J, Ikematsu S, et al. Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. AIDS 1990;4:1251-5.
32. Miles SA, Mitsuyasu RT, Moreno J, et al. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 1991; 77:2109-17.
33. van der Wouw PA, van Leeuwen R, van Oers RHJ, Lange JMA, Danner SA. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS-related complex, a phase I/II study. Br J Haematol 1991;78:319-24.
34. 6/L [Abstract]. Proc Eleventh Int Conf AIDS, 1996;WeA 3094.
35. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 1990;59:783-836.
36. Kovacs JA, Baseler M, Dewar RJ, et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med 1995;332:567-75.
37. Barrick B, Vogel SE, Dugan FA, Engle JE, Lane HC, Kovacs JA. Quality of life and symptom distress in HIV-infected persons receiving intravenous interleukin-2 (IL-2) [Abstract]. Proc Eleventh Int Conf AIDS, 1996;WeB 3201.
38. Scadden DT, Levine JD, Bresnahan J, et al. In vivo effects of interleukin 3 in HIV type 1-infected patients with cytopenia. AIDS Res Hum Retrovir 1995;11:731-40.
39. Koyanagi Y, O'Brien WA, Zhao JQ, Golde DW, Gasson JC, Chen ISY. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 1988;241:1673-5.
40. Perno C-F, Yarchoan R, Cooney DA, et al. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J Exp Med 1989;169:933-51.
41. Hewitt RG, Morse GD, Lawrence WD, et al. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex. Antimicrob Agents Chemother 1993;37: 512-22.
42. Scadden DT, Pickus O, Hammer SM, et al. Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1. AIDS Res Hum Retrovir 1996;12: 1151-9.